FDA issued a Warning Letter to Standard Homeopathic Company, Inc. on 9/25/2013 for a previous inspection.
483 Standard Homeopathic Company Oct 2018

483 Standard Homeopathic Company Oct 2018

Taichun Qin FDA$119.00 - Available Now

FDA investigators audited the Standard Homeopathic Company - Los Angeles, CA, United States facility and issued inspectional observations (via FDA 483) on 03 Oct 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 03 Oct 2018
  • Location: Los Angeles, United States
  • FEI: 2010939
Add To Cart